Your browser doesn't support javascript.
loading
HLA-B*1502 haplotype screening prior to carbamazepine administration in individuals of south-east Asian ancestry nears cost-effectiveness in preventing severe cutaneous adverse drug reactions.
Kim, Emma; McCrossin, Ian; Frew, John W.
Affiliation
  • Kim E; University of New South Wales, Sydney, New South Wales, Australia.
  • McCrossin I; Department of Dermatology, Liverpool Hospital, Sydney, New South Wales, Australia.
  • Frew JW; University of New South Wales, Sydney, New South Wales, Australia.
Australas J Dermatol ; 59(3): 245-246, 2018 Aug.
Article in En | MEDLINE | ID: mdl-29226308
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carbamazepine / Genetic Testing / Stevens-Johnson Syndrome / HLA-B15 Antigen / Anticonvulsants Type of study: Diagnostic_studies / Etiology_studies / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Humans Country/Region as subject: Asia / Oceania Language: En Journal: Australas J Dermatol Year: 2018 Document type: Article Affiliation country: Australia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carbamazepine / Genetic Testing / Stevens-Johnson Syndrome / HLA-B15 Antigen / Anticonvulsants Type of study: Diagnostic_studies / Etiology_studies / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Humans Country/Region as subject: Asia / Oceania Language: En Journal: Australas J Dermatol Year: 2018 Document type: Article Affiliation country: Australia